Dare Bioscience Inc.

NASDAQ: DARE
Share price (1/3/25): $3.37
Market cap (1/3/25): $29.3 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Prospectus supplement

Exempt offering of securities

Initial registration of new securities

Prospectus supplement for primary offering

Prospectus supplement

Ownership Filter

Grossman Jessica D.

Steele Robin Joan

Rastetter William H

Kelley Susan L.

News Filter

Daré Bioscience Announces Phase 3 Plans for Sildenafil Cream, 3.6%, in the Treatment of Female Sexual Arousal Disorder

Daré Bioscience Reports Third Quarter 2024 Financial Results and Provides Company Update

Material Disclosure, Financial Statements or Exhibits

Daré Bioscience Selected to Receive $10 Million Award From ARPA-H’s Sprint for Women’s Health

Daré Bioscience Announces Common Stock Purchase Agreement for Up to $15 Million With Lincoln Park Capital Fund, LLC

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC